MabVax Therapeutics Holdings News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

10.07.18	MBVX Nears D Day, BNTC Soars On AXON Deal, DEPO Catches Eyes, APEN Up 47% YTD (RTTNews)
09.07.18	Will This News Move These Stocks Today? (RTTNews)
06.07.18	BIIB One Step Closer, MBVX To Be Delisted, RGLS In The Red On Pink Slip Woes (RTTNews)
03.07.18	FDA Nod For ALKS, TRXC Sees 4-fold Increase In Q2 Revenue, BCLI On Watch (RTTNews)
09.06.18	MABVAX INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In MabVax Therapeutics Holdings, Inc. To Contact The Firm (PR Newswire)
06.06.18	Johnson Fistel Announces Investigations of Fannie Mae and Freddie Mac, ADT Inc., MabVax Therapeutics Holdings, Inc. and Aegean Marine Petroleum Network Inc.; Investors Encouraged to Contact Firm (PR Newswire)
05.06.18	SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against MabVax Therapeutics Holdings (MBVX) & Lead Plaintiff Deadline - August 3, 2018 (PR Newswire)
05.06.18	MabVax Class Action: Bernstein Liebhard LLP Announces That A Securities Class Action Lawsuit Has Been Filed Against MabVax Therapeutics Holdings, Inc. - MBVX (PR Newswire)
24.05.18	MabVax Therapeutics Receives Nasdaq Notification Due to Late Form 10-Q (PR Newswire)
17.05.18	MabVax Therapeutics Receives U.S. Patent for Fully Human Antibodies Targeting the Antigen GD2 Expressed on Sarcoma, Melanoma, and Neuroblastoma (PR Newswire)
15.05.18	ALL Eyes On PRPH, TNDM Soars On Analyst Upgrade, OMER Back In Focus (RTTNews)
07.05.18	MabVax Therapeutics Presentation from VirtualInvestorConferences.com Now Available for On-Demand Viewing (PR Newswire)
07.05.18	MabVax Therapeutics Presentation from VirtualInvestorConferences.com Now Available for On-Demand Viewing (PR Newswire)
30.04.18	Live Investor Conference & Webinar: NASDAQ, NYSE, and OTC companies present May 3rd (PR Newswire)
30.04.18	Live Investor Conference & Webinar: NASDAQ, NYSE, and OTC companies present May 3rd (PR Newswire)
30.04.18	MabVax Therapeutics to Present an Interactive Live Webcast at VirtualInvestorConferences.com (PR Newswire)
30.04.18	MabVax Therapeutics to Present an Interactive Live Webcast at VirtualInvestorConferences.com (PR Newswire)
18.04.18	MabVax Therapeutics Antibody Program Results Featured in Three Presentations at 2018 American Association for Cancer Research (AACR) Annual Meeting (PR Newswire)
13.04.18	MabVax Therapeutics Receives Continued Listing Deficiency Notice for Nasdaq's Minimum Stockholders' Equity Requirements (PR Newswire)
02.04.18	MabVax Therapeutics Reports 2017 Operational and Financial Results and 2018 Milestones (PR Newswire)
15.03.18	MabVax Therapeutics Announces Acceptance of Three Poster Presentations at the 2018 American Association for Cancer Research (AACR) Annual Meeting (PR Newswire)
06.03.18	MabVax Therapeutics Regains Compliance with NASDAQ's $1.00 Minimum Bid Price Maintenance Requirement (PR Newswire)
28.02.18	MabVax Therapeutics Reports Positive Safety Results from Initial Cohort of MVT-1075 Radioimmunotherapy Phase 1 Trial for the Treatment of Pancreatic, Colon and Lung Cancers (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Alcon	78.04	2.36 %	K V
CieFinRichemont	123.20	1.69 %	K V
Lonza Grp	531.80	0.99 %	K V
Logitech Intl	72.58	0.53 %	K V
Novartis	92.30	0.40 %	K V
Geberit	523.20	-0.57 %	K V
Swisscom	505.50	-0.69 %	K V
ABB	49.52	-0.88 %	K V
Holcim	88.80	-1.09 %	K V
UBS Group	27.78	-2.01 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu MabVax Therapeutics Holdings Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten